1-2 of 2
Saul E. Rivkin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911

Clinical Trials & Observations
Oliver W. Press, Joseph M. Unger, Rita M. Braziel, David G. Maloney, Thomas P. Miller, Michael LeBlanc, Ellen R. Gaynor, Saul E. Rivkin, Richard I. Fisher
Journal: Blood
Blood (2003) 102 (5): 1606–1612.
https://doi.org/10.1182/blood-2003-01-0287
Published: 2003
Journal Articles

Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003)

Clinical Trials & Observations
Madhav V. Dhodapkar, Joth L. Jacobson, Morie A. Gertz, Saul E. Rivkin, G. David Roodman, Joseph M. Tuscano, Muhammad Shurafa, Robert A. Kyle, John J. Crowley, Bart Barlogie
Journal: Blood
Blood (2001) 98 (1): 41–48.
https://doi.org/10.1182/blood.V98.1.41
Published: 2001